Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2010

01-05-2010 | Educational Series

The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment

Authors: Carmen Faus, Desamparados Roda, Matteo Frasson, Susana Roselló, Eduardo García-Granero, Blas Flor-Lorente, Samuel Navarro

Published in: Clinical and Translational Oncology | Issue 5/2010

Login to get access
Metadata
Title
The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment
Authors
Carmen Faus
Desamparados Roda
Matteo Frasson
Susana Roselló
Eduardo García-Granero
Blas Flor-Lorente
Samuel Navarro
Publication date
01-05-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-010-0515-7

Other articles of this Issue 5/2010

Clinical and Translational Oncology 5/2010 Go to the issue

Editorial

Treatment of localised prostate cancer with radiation therapy: evidence versus opinion

Research Article

Comparison of positron emission tomography (PET) and computed tomography (CT) for better target volume definition in radiation therapy planning

Educational Series

Evidence-based consensus recommendations to improve the quality of life in prostate cancer treatment

Case Reports

Haemolytic uraemic syndrome associated with gemcitabine

Special Article

TTD consensus document on the diagnosis and management of hereditary colorectal cancer

Educational Series

The insulin-like growth factor pathway as a target for cancer therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits